Clinical trial
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in…
NCT00056654 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00056654 |
|---|---|
| Title | Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer |
| Official title | Pharmacokinetic, Safety and Efficacy Study of a Six-Month Depot Formulation of Leuprolide in Subjects With Prostatic Carcinoma |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Drug |
| Interventions | Leuprolide acetate |
| Enrollment | 164 |
| Start date | Mar 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Mar 21, 2003 |
| Last update posted | Sep 17, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: